- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.69 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 10 x CA: CALCIUM ION(Non-covalent)(Non-functional Binders)
CA.3: 5 residues within 4Å:- Chain A: D.213, G.217, D.243, G.261, N.263
6 PLIP interactions:5 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.213, A:G.217, A:D.243, A:G.261, A:N.263, H2O.2
CA.4: 4 residues within 4Å:- Chain A: D.295, N.297, D.303, N.305
5 PLIP interactions:3 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.295, A:D.303, A:N.305, H2O.6, H2O.7
CA.5: 1 residues within 4Å:- Ligands: CA.27
No protein-ligand interaction detected (PLIP)CA.15: 5 residues within 4Å:- Chain B: D.213, G.217, D.243, G.261, N.263
6 PLIP interactions:5 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.213, B:G.217, B:D.243, B:G.261, B:N.263, H2O.16
CA.16: 4 residues within 4Å:- Chain B: D.295, N.297, D.303, N.305
5 PLIP interactions:3 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.295, B:D.303, B:N.305, H2O.21, H2O.24
CA.25: 5 residues within 4Å:- Chain C: D.213, G.217, D.243, G.261, N.263
6 PLIP interactions:5 interactions with chain C, 1 Ligand-Water interactions- Metal complexes: C:D.213, C:G.217, C:D.243, C:G.261, C:N.263, H2O.33
CA.26: 4 residues within 4Å:- Chain C: D.295, N.297, D.303, N.305
5 PLIP interactions:3 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:D.295, C:D.303, C:N.305, H2O.36, H2O.38
CA.27: 1 residues within 4Å:- Ligands: CA.5
No protein-ligand interaction detected (PLIP)CA.37: 5 residues within 4Å:- Chain D: D.213, G.217, D.243, G.261, N.263
6 PLIP interactions:5 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.213, D:G.217, D:D.243, D:G.261, D:N.263, H2O.47
CA.38: 4 residues within 4Å:- Chain D: D.295, N.297, D.303, N.305
5 PLIP interactions:3 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:D.295, D:D.303, D:N.305, H2O.52, H2O.54
- 4 x G39: (3R,4R,5S)-4-(acetylamino)-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid(Non-covalent)
G39.6: 14 residues within 4Å:- Chain A: R.37, E.38, D.70, R.71, W.98, I.142, R.144, S.166, E.196, E.197, R.212, N.214, R.287, Y.321
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:W.98, A:I.142
- Hydrogen bonds: A:E.38, A:R.71
- Water bridges: A:D.70, A:R.71, A:R.75, A:R.212
- Salt bridges: A:R.37, A:R.212, A:R.287
G39.17: 14 residues within 4Å:- Chain B: R.37, E.38, D.70, R.71, W.98, I.142, R.144, S.166, E.196, E.197, R.212, N.214, R.287, Y.321
14 PLIP interactions:14 interactions with chain B- Hydrophobic interactions: B:W.98, B:I.142
- Hydrogen bonds: B:E.38, B:R.71, B:Y.321
- Water bridges: B:D.70, B:D.70, B:R.75, B:E.197, B:E.197, B:R.212
- Salt bridges: B:R.37, B:R.212, B:R.287
G39.28: 14 residues within 4Å:- Chain C: R.37, E.38, D.70, R.71, W.98, I.142, R.144, S.166, E.196, E.197, R.212, N.214, R.287, Y.321
14 PLIP interactions:14 interactions with chain C- Hydrophobic interactions: C:W.98, C:I.142
- Hydrogen bonds: C:E.38, C:R.71, C:Y.321
- Water bridges: C:R.71, C:R.75, C:R.75, C:E.147, C:E.197, C:R.212
- Salt bridges: C:R.37, C:R.212, C:R.287
G39.39: 14 residues within 4Å:- Chain D: R.37, E.38, D.70, R.71, W.98, I.142, R.144, S.166, E.196, E.197, R.212, N.214, R.287, Y.321
11 PLIP interactions:11 interactions with chain D- Hydrophobic interactions: D:W.98, D:I.142
- Hydrogen bonds: D:E.38, D:R.71
- Water bridges: D:D.70, D:R.75, D:E.197, D:R.212
- Salt bridges: D:R.37, D:R.212, D:R.287
- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.7: 8 residues within 4Å:- Chain A: W.318, I.346, R.347, G.348, R.349, P.350, K.351, E.352
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:W.318, A:G.348, A:K.351, A:E.352
GOL.10: 5 residues within 4Å:- Chain A: P.12, V.13, Y.272, W.277, W.294
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:V.13, A:W.277
GOL.18: 8 residues within 4Å:- Chain B: W.318, I.346, R.347, G.348, R.349, P.350, K.351, E.352
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:W.318, B:G.348, B:R.349, B:K.351
GOL.29: 8 residues within 4Å:- Chain C: W.318, I.346, R.347, G.348, R.349, P.350, K.351, E.352
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:W.318, C:G.348, C:K.351, C:E.352, C:E.352
GOL.32: 5 residues within 4Å:- Chain C: P.12, V.13, Y.272, W.277, W.294
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:V.13, C:W.277
GOL.40: 8 residues within 4Å:- Chain D: W.318, I.346, R.347, G.348, R.349, P.350, K.351, E.352
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:W.318, D:G.348, D:R.349, D:K.351, D:E.352
- 14 x ACT: ACETATE ION(Non-functional Binders)
ACT.8: 5 residues within 4Å:- Chain A: L.46, E.47, C.48
- Chain D: N.128, I.130
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Y.19
ACT.9: 6 residues within 4Å:- Chain A: S.14, I.308, K.309, Q.310, T.371, V.372
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.308
- Hydrogen bonds: A:T.371
- Water bridges: A:G.373, A:G.373
ACT.11: 3 residues within 4Å:- Chain A: N.192, Y.193, P.256
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:Y.193
- Hydrogen bonds: A:N.192
ACT.19: 7 residues within 4Å:- Chain B: S.14, I.308, K.309, Q.310, T.371, V.372
- Ligands: ACT.20
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:I.308
- Hydrogen bonds: B:T.371
- Water bridges: B:G.373, B:G.373
ACT.20: 5 residues within 4Å:- Chain B: K.309, Q.310, D.311, G.373
- Ligands: ACT.19
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:D.311, B:D.311, B:G.373
- Water bridges: B:D.311
- Salt bridges: B:K.309
ACT.21: 7 residues within 4Å:- Chain A: N.128, G.129, I.130
- Chain B: Y.19, L.46, E.47, C.48
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:E.47
- Hydrogen bonds: B:Y.19, B:Y.19, B:C.48
ACT.22: 4 residues within 4Å:- Chain B: E.352, N.353, L.382, P.383
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:E.352, B:N.353
- Hydrogen bonds: B:N.353
ACT.30: 5 residues within 4Å:- Chain B: N.128, I.130
- Chain C: L.46, E.47, C.48
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:Y.19
ACT.31: 6 residues within 4Å:- Chain C: S.14, I.308, K.309, Q.310, T.371, V.372
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:I.308
- Hydrogen bonds: C:T.371, C:T.371
- Water bridges: C:G.373, C:G.373
ACT.33: 3 residues within 4Å:- Chain C: N.192, Y.193, P.256
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:Y.193
- Hydrogen bonds: C:N.192
ACT.41: 7 residues within 4Å:- Chain D: S.14, I.308, K.309, Q.310, T.371, V.372
- Ligands: ACT.42
5 PLIP interactions:5 interactions with chain D- Hydrophobic interactions: D:I.308
- Hydrogen bonds: D:T.371, D:T.371
- Water bridges: D:G.373, D:G.373
ACT.42: 5 residues within 4Å:- Chain D: K.309, Q.310, D.311, G.373
- Ligands: ACT.41
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:D.311, D:D.311, D:G.373
- Salt bridges: D:K.309
ACT.43: 7 residues within 4Å:- Chain C: N.128, G.129, I.130
- Chain D: Y.19, L.46, E.47, C.48
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:E.47
- Hydrogen bonds: D:Y.19, D:C.48
ACT.44: 4 residues within 4Å:- Chain D: E.352, N.353, L.382, P.383
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:E.352, D:N.353
- Hydrogen bonds: D:N.353
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vavricka, C.J. et al., Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition. Plos Pathog. (2011)
- Release Date
- 2011-11-23
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.69 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 10 x CA: CALCIUM ION(Non-covalent)(Non-functional Binders)
- 4 x G39: (3R,4R,5S)-4-(acetylamino)-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid(Non-covalent)
- 6 x GOL: GLYCEROL(Non-functional Binders)
- 14 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vavricka, C.J. et al., Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition. Plos Pathog. (2011)
- Release Date
- 2011-11-23
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B